Mohit Bansal Analyst PerformanceBiopharma Equity Research Analyst at Wells Fargo & CompanyMohit Bansal is a stock analyst at Wells Fargo & Company in the healthcare sector, covering 22 publicly traded companies. Over the past year, Mohit Bansal has issued 51 stock ratings, including buy and hold recommendations. While full access to Mohit Bansal's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Mohit Bansal's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings81 Last 11 YearsBuy Recommendations65.38% 51 Buy RatingsCompanies Covered22 Unique Companies Ratings Distribution78RatingsDistribution of strong buy, buy, hold, and sell ratings by Mohit Bansal.RatingPercentageCount Strong Buy0.0%0 ratings Buy65.4%51 ratings Hold34.6%27 ratings Sell0.0%0 ratingsOut of 78 total stock ratings issued by Mohit Bansal at Wells Fargo & Company, the majority (65.4%) have been Buy recommendations, followed by 34.6% Hold.Best & Worst CallsBest Call000.0%XENEMay 2025Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%CHRSNov 2016Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ81.8% of companies on NASDAQ18 companiesNYSE18.2% of companies on NYSE4 companiesMohit Bansal, an analyst at Wells Fargo & Company, currently covers 22 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageHealthcare22 companies100.0%Mohit Bansal of Wells Fargo & Company specializes in stock coverage within the Healthcare sector.Coverage IndustriesIndustryPercentageBIOTECHNOLOGY14 companies63.6%PHARMACEUTICALS8 companies36.4% Mohit Bansal's Ratings History at Wells Fargo & Company Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsBMYBristol Myers Squibb7/31/2026Set Price Target$64.98$65.00Equal Weight$0.0000.00% ROIREGNRegeneron Pharmaceuticals7/31/2026Boost Price Target$738.90$750.00Equal Weight$0.0000.00% ROINBIXNeurocrine Biosciences7/17/2026Boost Price Target$171.93$200.00Overweight$0.0000.00% ROIJAZZJazz Pharmaceuticals7/14/2026Boost Price Target$236.97$285.00Overweight$0.0000.00% ROIABBVAbbVie7/10/2026Boost Price Target$249.98$295.00Overweight$0.0000.00% ROIMRKMerck & Co., Inc.7/8/2026Boost Price Target$128.87$150.00Overweight$0.0000.00% ROITVTXTravere Therapeutics6/12/2026Boost Price Target$50.30$65.00Overweight$0.0000.00% ROIREGNRegeneron Pharmaceuticals5/18/2026Lower Price Target$623.32$700.00Equal Weight$0.0000.00% ROIMISTMilestone Pharmaceuticals5/14/2026Lower Price Target$1.60$7.00Overweight$0.0000.00% ROIJAZZJazz Pharmaceuticals5/6/2026Boost Price Target$225.36$265.00Overweight$0.0000.00% ROI Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. TVTXTravere Therapeutics5/6/2026Boost Price Target$43.65$50.00Overweight$0.0000.00% ROIBNTXBioNTech5/6/2026Lower Price Target$93.28$140.00Overweight$0.0000.00% ROIMRKMerck & Co., Inc.5/1/2026Lower Price Target$113.14$145.00Overweight$0.0000.00% ROIREGNRegeneron Pharmaceuticals4/30/2026Lower Price Target$699.16$800.00Equal Weight$0.0000.00% ROIMRKMerck & Co., Inc.3/12/2026Boost Price Target$116.21$150.00Overweight$0.0000.00% ROIJAZZJazz Pharmaceuticals2/25/2026Boost Price Target$194.17$250.00Overweight$0.0000.00% ROIAMGNAmgen2/19/2026Boost Price Target$379.73$375.00Equal Weight$0.0000.00% ROIHALOHalozyme Therapeutics2/19/2026Boost Price Target$72.39$75.00Equal Weight$0.0000.00% ROIBMRNBioMarin Pharmaceutical2/18/2026Boost Price Target$59.89$75.00Overweight$0.0000.00% ROINBIXNeurocrine Biosciences2/13/2026Lower Price Target$126.01$175.00Overweight$0.0000.00% ROIGILDGilead Sciences2/11/2026Boost Price Target$147.23$165.00Overweight$0.0000.00% ROIBIIBBiogen2/8/2026Boost Price Target$201.18$200.00Equal Weight$0.0000.00% ROIBMYBristol Myers Squibb2/6/2026Reiterated Rating$59.43$60.00Outperform$0.0000.00% ROILLYEli Lilly and Company2/5/2026Boost Price Target$1,107.13$1,280.00Overweight$0.0000.00% ROIMRKMerck & Co., Inc.2/4/2026Boost Price Target$118.49$135.00Overweight$0.0000.00% ROIREGNRegeneron Pharmaceuticals2/2/2026Boost Price Target$758.49$800.00Equal Weight$0.0000.00% ROIIRWDIronwood Pharmaceuticals1/5/2026Boost Price Target$4.68$5.00Equal Weight$0.0000.00% ROIMISTMilestone Pharmaceuticals12/16/2025Boost Price Target$2.35$8.00Overweight$0.0000.00% ROIAMGNAmgen12/10/2025Boost Price Target$313.85$325.00Equal Weight$0.0000.00% ROIBIIBBiogen12/10/2025Boost Price Target$175.84$190.00Equal Weight$0.0000.00% ROIGILDGilead Sciences12/10/2025Boost Price Target$119.36$150.00Overweight$0.0000.00% ROILLYEli Lilly and Company12/10/2025Boost Price Target$995.62$1,200.00Overweight$0.0000.00% ROIBMYBristol Myers Squibb12/10/2025Boost Price Target$51.49$55.00Equal Weight$0.0000.00% ROIVRTXVertex Pharmaceuticals12/10/2025Boost Price Target$444.95$515.00Overweight$0.0000.00% ROIREGNRegeneron Pharmaceuticals12/10/2025Boost Price Target$721.91$745.00Equal Weight$0.0000.00% ROIAMGNAmgen11/25/2025Set Price Target$334.30$400.00$0.0000.00% ROIMRKMerck & Co., Inc.11/24/2025Upgrade$97.78$125.00Overweight$0.0000.00% ROIREGNRegeneron Pharmaceuticals11/20/2025Boost Price Target$748.91$700.00Equal Weight$0.0000.00% ROIJAZZJazz Pharmaceuticals11/18/2025Boost Price Target$180.51$235.00Overweight$0.0000.00% ROIIRWDIronwood Pharmaceuticals11/11/2025Boost Price Target$2.53$3.00Equal Weight$0.0000.00% ROIYour $29.97 book is free today (Ad)Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.Normally $29.97. Today it's free. Grab your copy now.MLYSMineralys Therapeutics11/11/2025Boost Price Target$42.89$55.00Overweight$0.0000.00% ROIAMGNAmgen11/5/2025Boost Price Target$296.70$300.00Overweight$0.0000.00% ROIGILDGilead Sciences10/31/2025Boost Price Target$118.44$145.00Overweight$0.0000.00% ROIREGNRegeneron Pharmaceuticals10/29/2025Boost Price Target$655.09$615.00Equal Weight$0.0000.00% ROIBMRNBioMarin Pharmaceutical10/28/2025Lower Price Target$54.93$70.00Overweight$0.0000.00% ROIABBVAbbVie9/12/2025Boost Price Target$220.09$260.00Overweight$0.0000.00% ROIMISTMilestone Pharmaceuticals9/11/2025Initiated Coverage$1.71$4.00Overweight$0.0000.00% ROITVTXTravere Therapeutics9/11/2025Boost Price Target$27.31$35.00Overweight$0.0000.00% ROIMLYSMineralys Therapeutics9/11/2025Boost Price Target$38.56$50.00Overweight$0.0000.00% ROIVRTXVertex Pharmaceuticals8/6/2025Upgrade$374.98$460.00Overweight$0.0000.00% ROIBNTXBioNTech8/5/2025Set Price Target$110.04$150.00Overweight$0.0000.00% ROIREGNRegeneron Pharmaceuticals8/1/2025Downgrade$545.46$580.00Equal Weight$0.0000.00% ROIMRKMerck & Co., Inc.7/30/2025Lower Price Target$83.21$90.00Equal Weight$000.0000.00% ROIREGNRegeneron Pharmaceuticals5/30/2025Downgrade$605.39$580.00Equal Weight$000.0000.00% ROIXENEXenon Pharmaceuticals5/13/2025Lower Price Target$29.95$47.00Overweight$00.0000.00% ROIHALOHalozyme Therapeutics5/7/2025Boost Price Target$68.49$65.00Equal Weight$00.0000.00% ROIREGNRegeneron Pharmaceuticals4/30/2025Lower Price Target$586.51$700.00Overweight$000.0000.00% ROIIRWDIronwood Pharmaceuticals4/15/2025Reiterated Rating$0.65$1.00Equal Weight$0.0000.00% ROILLYEli Lilly and Company3/5/2025Boost Price Target$917.63$1,100.00Overweight$0000.0000.00% ROIABBVAbbVie3/5/2025Boost Price Target$208.49$240.00Overweight$000.0000.00% ROIJAZZJazz Pharmaceuticals2/13/2025Upgrade$135.44$170.00Overweight$000.0000.00% ROIBIIBBiogen2/13/2025Lower Price Target$134.10$140.00Equal Weight$000.0000.00% ROIBIIBBiogen2/12/2025Set Price Target$140.64$165.00$000.0000.00% ROIBMYBristol Myers Squibb2/7/2025Boost Price Target$57.21$62.00Equal Weight$00.0000.00% ROIABBVAbbVie2/3/2025Boost Price Target$188.80$210.00Overweight$000.0000.00% ROIVRTXVertex Pharmaceuticals1/30/2025Downgrade$441.52$460.00Equal Weight$000.0000.00% ROILLYEli Lilly and Company1/28/2025Lower Price Target$808.16$970.00Overweight$0000.0000.00% ROIVRTXVertex Pharmaceuticals1/10/2025Lower Price Target$412.11$460.00Overweight$000.0000.00% ROIREGNRegeneron Pharmaceuticals1/10/2025Lower Price Target$733.59$900.00Overweight$000.0000.00% ROIBIIBBiogen1/10/2025Lower Price Target$150.75$165.00Equal Weight$000.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenJefferies Financial GroupUBS GroupThe Goldman Sachs GroupWeiss RatingsCitigroupBarclaysRoyal Bank Of CanadaMorgan StanleyWells Fargo & CompanyJPMorgan Chase & Co.TD CowenTruist FinancialPiper SandlerDeutsche Bank Aktiengesellschaft Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
